Neogen Corporation

NEOG Healthcare Medical Devices

Neogen Corporation’s revenue for fiscal 2026 (year ended May 2026) was $870.4 million, down 2.72% from fiscal 2025.

Revenue
+6.50%
EPS
−129.4%
Free cash flow
+135.6%
Total debt
−2.31%

Quarter to August 2026, against a year earlier

11.88 0.20 +1.71%
Market cap
$2.6B
P/E
0.0×
Fwd P/E
−93.3×
Dividend yield
—
F-score
5/9
Altman Z
1.11
Beneish M
−2.43
Dividend safety
n/a
May '26 May '25 May '24 May '23 May '22 May '21 May '20 May '19 May '18 May '17
Piotroski F-Score
5 3 5 3 6 4 5 5 6 5
P/E ratio
0.00 0.00 0.00 0.00 58.80 79.34 63.58 49.01 62.44 55.50
Altman Z-Score
1.11 (0.28) 1.75 1.89 18.41 39.25 33.57 32.80 42.83 27.86
P/S ratio
2.23 1.38 3.08 4.02 5.41 10.37 9.03 7.06 9.77 6.70
Altman Z″-Score (non-manufacturers)
2.06 (0.23) 3.46 3.41 14.78 17.34 17.12 18.08 16.41 14.59
P/FCF ratio
60.63 0.00 0.00 0.00 65.34 89.35 61.06 59.46 80.71 52.50
Beneish M-Score
(2.43) (4.34) (2.43) (1.92) (2.63) (2.43) (2.69) (2.46) (2.43) (2.62)
P/Operating CF
64.24 75.25 106.30 36.32 139.74 221.15 147.31 140.08 172.42 159.01
P/B ratio
0.93 0.60 0.91 1.05 3.21 5.78 5.21 4.58 6.94 5.08
EV/Sales
2.95 2.23 3.86 4.80 4.68 9.56 8.21 6.41 9.24 6.29
EV/EBITDA
25.10 14.64 19.41 30.19 29.84 47.04 39.95 31.00 42.15 28.32
EV/FCF
80.24 (48.41) (46.93) (165.10) 56.62 82.36 55.52 54.02 76.33 49.35
Current Ratio
3.82 3.32 3.82 4.03 8.05 11.03 11.08 11.75 9.71 8.14
Net Debt/EBITDA
5.95 5.60 3.92 4.92 (4.59) (3.99) (3.99) (3.12) (2.42) (1.80)
Debt/Equity
0.38 0.43 0.28 0.28 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(0.38%) (41.88%) (0.30%) (1.14%) 5.59% 7.78% 8.73% 10.05% 12.24% 10.00%
ROA
(0.23%) (27.33%) (0.21%) (0.82%) 5.05% 7.09% 7.97% 9.16% 11.02% 8.95%
ROIC
(0.50%) (23.38%) 0.95% 0.62% 7.22% 10.07% 11.03% 11.49% 12.56% 12.37%
Return on Tangible Assets
(1.02%) (147.17%) (1.32%) (3.58%) 7.32% 9.54% 10.48% 12.38% 15.39% 13.74%
Average Days of Receivables
61.56 62.58 68.33 68.01 69.01 71.54 73.91 72.78 72.54 69.86
Earnings Yield
(0.34%) (88.40%) (0.33%) (0.40%) 1.70% 1.26% 1.57% 2.04% 1.60% 1.80%
Free Cash Flow Yield
1.65% (3.35%) (2.67%) (0.72%) 1.53% 1.12% 1.64% 1.68% 1.24% 1.90%
Free Cash Flow per Share
0.15 (0.19) (0.35) (0.13) 0.41 0.51 0.59 0.47 0.47 0.45
Book value per Share
9.62 9.55 14.52 16.59 8.24 7.89 6.90 6.15 5.45 4.67
Free Cash Flow
32.00 (41.30) (76.00) (23.90) 43.61 54.38 61.83 49.18 48.19 45.70
EV/EBIT
0.00 0.00 60.87 105.20 42.12 60.38 50.84 39.02 52.40 34.72
Other line items

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026